Stereotactic Body Radiation Therapy vs. Surgery for Stage I NSCLC
Okay, here’s a breakdown of the provided text, summarizing the key findings of the study and its limitations.
Study Summary: SBRT vs. lobectomy for Stage I NSCLC
This retrospective study, conducted at Ajou University Hospital between 2016 and 2021, compared the outcomes of Stereotactic Body Radiation Therapy (SBRT) and lobectomy (surgical removal of a lung lobe) for patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
Key Findings:
* Overall Survival (OS): Comparable between SBRT and lobectomy groups (3-year OS: 90.0% vs 93.0% before matching).
* Disease-Free survival (DFS): Initially better in the surgery group, but the difference lessened after Propensity Score Matching (PSM). (Before PSM: 54.5% vs 78.1%; After PSM: 54.4% vs 68.2%).
* Recurrence:
* Local Recurrence: Significantly higher in the SBRT group (19.4%) compared to the surgery group (0%).
* Regional & Distant Recurrence: No significant differences between the two groups.
* Age Difference: The SBRT group was significantly older than the lobectomy group, both before and after PSM (79.6 [5.1] vs 72.7 [4.9] years after PSM).
Study Details:
* Participants: 214 patients (93 lobectomy, 31 SBRT).
* Exclusion Criteria: Double primary lung cancers, history of other malignancies within 5 years.
* Propensity Score Matching (PSM): Used to attempt to balance the groups and account for differences in baseline characteristics.
Limitations:
* Retrospective Design: Limits the ability to establish cause-and-effect relationships.
* Single Center: Results may not be generalizable to other populations or healthcare settings.
* Short Follow-Up Period: Limits assessment of long-term outcomes.
* Small Sample Size: May reduce the statistical power of the study.
* Age Disparity: A significant age difference between the groups persisted even after PSM, potentially influencing results.
* PSM Concerns: Potential for imperfect covariate balance despite using PSM.
Conclusion (as stated by the researchers):
Despite a higher rate of local recurrence, SBRT and lobectomy had similar overall survival and distant recurrence outcomes.
Let me know if you’d like me to elaborate on any specific aspect of this details!